Navigation Links
Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
Date:4/14/2008

Isis Will Host a Conference Call on Monday, April 14, at 8:30 a.m. E.T. at

http://www.isispharm.com

CARLSBAD, Calif., April 14 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced additional results from its ongoing Phase 2 open-label extension (OLE) study of mipomersen in patients with familial hypercholesterolemia (FH). In FH patients exposed to mipomersen for as long as 16 months, the safety profile of the drug continues to be encouraging. Reductions in LDL-cholesterol were also maintained in patients who had responded to treatment in their initial study and continued on treatment.

In this OLE study, patients with FH who were initially enrolled in one of two Phase 2 efficacy studies of mipomersen were allowed to enter the OLE study. All patients in the study were being treated with maximum-tolerated lipid-lowering therapy before and during the study. Most patients received 200 mg/week of mipomersen in addition to maximum-tolerated lipid-lowering therapy. The median duration of continuous exposure in these patients was 38 weeks. The maximum continuous exposure was 64 weeks.

All patients in the study had the opportunity to self-administer mipomersen. Although the study was not designed to measure efficacy, the activity of mipomersen was clearly demonstrated and appeared to be well maintained with longer-term dosing.

With respect to safety, the drug was well tolerated in longer-term treatment. There were no new types of adverse events observed and rates of adverse events decreased during the OLE study from those in the initial efficacy studies.
The following additional observations were made in thes
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
2. Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
5. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
6. Anti-Cancer Drug CYT997 Update
7. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
8. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
9. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
10. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
11. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013   NextDocs announced today ... clinical research organization, at DIA 2013 , the ... will present case studies that explore best practices for ... electronic trial master file (eTMF) systems. ... present alongside Krystyna Kowalczyk , executive vice president ...
(Date:6/19/2013)... CLARA, Calif. , June 19, 2013 /PRNewswire/ ... control solutions for life sciences process applications, announced ... glass bioreactors for upstream cell culture and fermentation.  ... a new product family of Finesse bioreactors and ... and cGMP applications.  They are fully compatible with ...
(Date:6/19/2013)... India , June 19, 2013 ... Bureau has recently added DrugPatentWatch to ... ( http://www.bharatbook.com/drugpatentwatch-tour.pdf )      ... provides comprehensive information on pharmaceutical, drug ... information supports the critical business functions ...
Breaking Medicine Technology:NextDocs and Novella to Present on eTMF at DIA 2013 2Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Drug Patent Watch 2Drug Patent Watch 3
... 13 Otix Global, Inc. (Otix) (Nasdaq: OTIX ... today announced that it has decided to discontinue its operations ... decision, Sam Westover, Chairman and CEO of Otix stated, "the ... stability of our business and, as a result, we have ...
... Applied Precision is sending its Mobile ... and research centers.   The Applied Precision ... 40-foot coach bus.  The lab is equipped with Applied ... a wet lab.  New this year is a special ...
Cached Medicine Technology:Otix Global, Inc. to Discontinue German Operations 2Otix Global, Inc. to Discontinue German Operations 3Applied Precision's Mobile Imaging Lab Hits the Road for a Cross-Country Journey 2
(Date:6/19/2013)... medicine and trauma surgery have had a significant ... immediately after major injuries, including burns. Patients ... now are at greatest risk from infections ... sepsis or from inflammation-induced multiorgan failure. ... (MGH) investigators that measures the movement of key ...
(Date:6/19/2013)... (June 19, 2013) In what is believed to ... most common form of hereditary dystonia a movement ... in deep brain stimulation report good success rates and ... the Movement Disorders Program at Cedars-Sinai Medical Center,s Department ... the Division of Neurosurgery at Beth Israel Deaconess Medical ...
(Date:6/19/2013)... The results of three important studies have been published ... journal of the Congress of Neurological Surgeons . ... & Wilkins , a part of Wolters Kluwer ... learning" using artificial neural networks (ANNs) may improve the ... cancers. Another study in the June Neurosurgery ...
(Date:6/19/2013)... Ann Arbor, Mich. Children had half as ... had evening office hours on five or more days ... experts at C.S. Mott Children,s Hospital and Johns Hopkins ... month in The Journal of Pediatrics and ... , "These findings are an important step in understanding ...
(Date:6/19/2013)... is available in Spanish . ... neglected diseases, it goes by the name of the 10/90 ... devoted to conditions that accounted for 90 per cent of ... that the Drugs for Neglected Diseases initiative (DNDi) came into ... organization has been granted the BBVA Foundation Frontiers of Knowledge ...
Breaking Medicine News(10 mins):Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5
... SAN FRANCISCO, Oct. 9 Genomic Health, Inc. (Nasdaq: ... demonstrating the critical role of manual microdissection to remove ... Health,s Onco type DX is the only commercially ... review by a board certified surgical pathologist with breast ...
... and LAKE FOREST, Calif., Oct. 9 Kimberly-Clark Corporation ... IFLO ), a leading healthcare company that develops and ... products for post-surgical pain relief and surgical site care, ... acquired in a cash tender offer for approximately $324 ...
... CEO Harrison Calls for Reform that Eliminates Wasteful Government ... 9 Doug Harrison, CEO and Founder of The SCOOTER ... of Health and Human Services (HHS) Inspector General,s report was ... costs of providing medical equipment to Medicare beneficiaries. , In ...
... of Ford Motor Company and the United Auto Workers are ... - they,re also coming together to support the March of ... start in life. , (Photo: http://www.newscom.com/cgi-bin/prnh/20091009/AQ90045 ) ... Dimes honored special volunteers and announced the first-ever March for ...
... ... employment law compliance obligations can now download a free 75-minute audio briefing entitled Employment ... discussion featuring five employment law attorneys with the Employers Counsel Network. , ... Nashville, TN (PRWEB) October 9, ...
... ... Physical Therapist has received a home exercise program, or HEP, that consisted of 2 to 3 ... FIZIO is a new online service that is set on changing this practice by giving health ... ...
Cached Medicine News:Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 2Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 3Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 4Health News:Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients 5Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 2Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 3Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 4Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 5Health News:Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation 6Health News:SCOOTER Store CEO Outraged: Flawed Data Used by Fox News Channel to Wrongly Chastise Medical Suppliers 2Health News:Ford and Labor Leaders Join Forces with March of Dimes 2Health News:New Audio Briefing Explains Obama Administration's Workplace Law Priorities 2Health News:New Audio Briefing Explains Obama Administration's Workplace Law Priorities 3Health News:New Online Service Uses Video Instruction to Simplify Physical Therapy Exercises 2Health News:New Online Service Uses Video Instruction to Simplify Physical Therapy Exercises 3Health News:New Online Service Uses Video Instruction to Simplify Physical Therapy Exercises 4
... more efficient way to control thermoregulation. ... operated patient warming system, provides hospitals, ... a compact and better way to ... process. Its unique design combines functionality ...
... WarmAir® system from CSZ safely provides effective ... of the unique patented design of our ... lower velocity blower which supplies gently moving, ... that may spread contaminants to your patient ...
Since 1964, in its plants of Sesto Fiorentino, Sbisà produces a wide and qualified range of instruments for ophthalmology and optometry....
Inquire...
Medicine Products: